These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1374777)
1. Comparison of four DNA staining fluorescence dyes for measuring cell proliferation of lymphokine-activated killer (LAK) cells. Vollenweider I; Groscurth P J Immunol Methods; 1992 Apr; 149(1):133-5. PubMed ID: 1374777 [No Abstract] [Full Text] [Related]
2. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts. Dannemann BR; Morris VA; Araujo FG; Remington JS J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453 [TBL] [Abstract][Full Text] [Related]
3. Fluorescent dyes for cell viability: an application on prefixed conditions. Foglieni C; Meoni C; Davalli AM Histochem Cell Biol; 2001 Mar; 115(3):223-9. PubMed ID: 11326750 [TBL] [Abstract][Full Text] [Related]
4. Changes in accessibility of DNA to various fluorochromes during spermatogenesis. Evenson D; Darzynkiewicz Z; Jost L; Janca F; Ballachey B Cytometry; 1986 Jan; 7(1):45-53. PubMed ID: 2419055 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells. Kondo S; Miyatake S; Kikuchi H; Oda Y; Iwasaki K; Ohyama K; Namba Y Neurosurgery; 1992 Sep; 31(3):534-40. PubMed ID: 1407434 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of adoptive immunotherapy: improved methods for in vivo tracking of tumor-infiltrating lymphocytes and lymphokine-activated killer cells. Wallace PK; Palmer LD; Perry-Lalley D; Bolton ES; Alexander RB; Horan PK; Yang JC; Muirhead KA Cancer Res; 1993 May; 53(10 Suppl):2358-67. PubMed ID: 8485722 [TBL] [Abstract][Full Text] [Related]
7. Regulatory effect of lymphokine-activated killer cells on epidermal proliferation induced by cholera toxin in mice. Okamoto Y; Tanaka N; Orita K Acta Med Okayama; 1994 Feb; 48(1):17-23. PubMed ID: 8191912 [TBL] [Abstract][Full Text] [Related]
8. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture. Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410 [TBL] [Abstract][Full Text] [Related]
9. [Effects of murine lymphokine-activated killer (LAK) cells on proliferation of myeloid progenitor cells (CFU-GM)]. Mao N; Jiang FZ; Zhang MW; Tang PH Shi Yan Sheng Wu Xue Bao; 1990 Mar; 23(1):11-6. PubMed ID: 2382523 [TBL] [Abstract][Full Text] [Related]
10. A new technique for retarding fading of fluorescence: DPX-BME. Franklin AL; Filion WG Stain Technol; 1985 May; 60(3):125-35. PubMed ID: 2411018 [TBL] [Abstract][Full Text] [Related]
11. Labeling nuclear DNA using DAPI. Chazotte B Cold Spring Harb Protoc; 2011 Jan; 2011(1):pdb.prot5556. PubMed ID: 21205856 [TBL] [Abstract][Full Text] [Related]
12. A fast and easy fluorescent counterstaining method for neuroanatomical studies by using Acridine Orange. López-Román A; Armengol JA J Neurosci Methods; 1995 Aug; 60(1-2):39-42. PubMed ID: 8544485 [TBL] [Abstract][Full Text] [Related]
13. Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist. Obligate paracrine pathway of IL-1 during lymphokine-activated killer cell induction. Fujiwara T; Grimm EA J Immunol; 1992 May; 148(9):2941-6. PubMed ID: 1374105 [TBL] [Abstract][Full Text] [Related]
14. Determining cell cycle stages by flow cytometry. Darzynkiewicz Z; Juan G; Bedner E Curr Protoc Cell Biol; 2001 May; Chapter 8():Unit 8.4. PubMed ID: 18228389 [TBL] [Abstract][Full Text] [Related]
15. Morphologic analysis of human lymphokine-activated killer (LAK) cells. Groscurth P; Diener S; Stahel R; Jost L; Kägi D; Hengartner H Int J Cancer; 1990 Apr; 45(4):694-704. PubMed ID: 2157676 [TBL] [Abstract][Full Text] [Related]
16. Impact of IL-2 and IL-2R SNPs on proliferation and tumor- killing activity of lymphokine-activated killer cells from healthy chinese blood donors. Li Y; Meng FD; Tian X; Sui CG; Liu YP; Jiang YH Asian Pac J Cancer Prev; 2014; 15(18):7965-70. PubMed ID: 25292096 [TBL] [Abstract][Full Text] [Related]
18. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells]. Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543 [TBL] [Abstract][Full Text] [Related]
19. Acridine orange-methyl green fluorescent staining of nucleoli. Franklin AL; Filion WG Stain Technol; 1981 Nov; 56(6):343-8. PubMed ID: 6176050 [TBL] [Abstract][Full Text] [Related]
20. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1. Triozzi PL; Eicher DM; Smoot J; Rinehart JJ Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]